Search
for
Sort by
Research 541–570 of 1000+
- Treatment of Alopecia Areata With Tofacitinib
- Tofacitinib therapy for children with severe alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Study of the efficacy of carboxytherapy in alopecia
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Alopecia Areata and Season of Onset: A Retrospective Study of 492 Cases
- The Ratio of Typical Clubbing in Pulled-Out Hairs as a Useful Marker in Predicting the Course of Alopecia Areata
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Dermoscopic Assessment of Nail Alterations in Egyptian Patients with Alopecia Areata
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- Amyopathic dermatomyositis presenting as severe alopecia and prominent eyelid edema: a case report and literature review
- Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study
- Psychometric validation of the Spanish alopecia areata–life impact questionnaire
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Clinical and demographic factors associated with nail involvement in adult alopecia areata patients at Al-Kadhmia teaching hospital, Baghdad, 2023
- Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Histopathologic prognostic factors for alopecia areata treated by intralesional corticosteroid
- Role of microneedling in treatment of alopecia areata